A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112

Clinical trial NCT03116113 · COMPLETED

Trial details

NCT number: NCT03116113
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

X-Linked Retinitis Pigmentosa

Start date: 2017-03-08
Primary completion: 2020-11-18
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.